SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

To go without masks and to refuse vaccines when there is no medical excuse is to declare an individual right to cause harm to ...

Her father told an interviewer that, no, he didn’t regret her vaccine status, and no, he had no plans to vaccinate his other ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

When smallpox reached the Americans... #documentary #nativeamerican ...

Emergent BioSolutions shares rose after the company disclosed that it will supply additional doses of CNJ-016, a treatment ...

Emergent BioSolutions (EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (A ...

Wiping out smallpox had an unintended consequence: the rise of mpox in the past few years. Here's the story — starting with patient zero for mpox back in 1970.

Throughout the course of human history, one infectious disease (Figure 1) may account for more deaths than any other, perhaps all others combined. Smallpox mortality falls between 20% and 50% ...

Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers report.

Smallpox has plagued humans since ancient Egyptian times, 2,000 years earlier than previously thought, according to new research. The disease was once one of humanity’s most devastating, but its ...